Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/49913
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJin D.-
dc.contributor.authorLoh K.L.-
dc.contributor.authorShamekhi T.-
dc.contributor.authorTing Y.T.-
dc.contributor.authorLim Kam Sian T.C.C.-
dc.contributor.authorRoest J.-
dc.contributor.authorOoi J.D.-
dc.contributor.authorVivian J.P.-
dc.contributor.authorFaridi P.-
dc.date.accessioned2023-07-13T06:40:52Z-
dc.date.available2023-07-13T06:40:52Z-
dc.date.copyright2023-
dc.date.issued2023-07-03en
dc.identifier.citationMethods in Molecular Biology. 2691 (pp 351-369), 2023. Date of Publication: 2023.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/49913-
dc.description.abstractEpitope-specific immunotherapies have enabled the targeted treatment of a variety of diseases, ranging from cancer, infection, and autoimmune disorders. For CD8+ T cell-based therapies, the precise identification of immunogenic peptides presented by human leukocyte antigen (HLA) class I is essential which can be achieved by immunopeptidomics. Here, using lentivirus-mediated transduction and cell sorting approaches, we present a method to engineer a cell line that does not express its native HLA but instead expresses an HLA of interest (in this instance HLA-A*02:01). This technique can be used to elucidate the immunopeptidome of cell lines expressing different HLAs.Copyright © 2023, The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.-
dc.publisherHumana Press Inc.-
dc.relation.ispartofMethods in Molecular Biology-
dc.subject.meshgene editing-
dc.subject.meshgene expression-
dc.subject.meshimmunotherapy-
dc.subject.meshLentivirus-
dc.subject.meshmalignant neoplasm-
dc.subject.meshprotein expression-
dc.subject.meshleukocyte antigen-
dc.titleEngineering Cell Lines for Specific Human Leukocyte Antigen Presentation.-
dc.typeChapter-
dc.identifier.affiliationMonash University - School of Clinical Sciences at Monash Health-
dc.identifier.affiliationCentre for Inflammatory Diseases at Monash Health-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1007/978-1-0716-3331-1_25-
dc.publisher.placeUnited States-
dc.identifier.pubmedid37355557 [https://www.ncbi.nlm.nih.gov/pubmed/?term=37355557]-
dc.identifier.institution(Jin, Shamekhi, Lim Kam Sian, Faridi) Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia-
dc.identifier.institution(Loh, Ting, Ooi) Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, VIC, Australia-
dc.identifier.institution(Lim Kam Sian, Faridi) Monash Proteomics & Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia-
dc.identifier.institution(Roest, Vivian) St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia-
dc.identifier.institution(Vivian) Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia-
dc.identifier.affiliationmhJin, Shamekhi, Lim Kam Sian, Faridi) Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia-
dc.identifier.affiliationmh(Loh, Ting, Ooi) Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, VIC, Australia-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeChapter-
Appears in Collections:Books and Book Chapters
Show simple item record

Page view(s)

62
checked on Nov 21, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.